by Kim Engqvist | Jun 22, 2020 | Press Releases
Kåre Engkilde, Chief Executive Officer, plans to present an overview of the company and provide a business update at the upcoming Virtual European Biotech Investor Day 2020 hosted by Solebury Trout, Goodwin, Deutsche Bank and Nasdaq. During the 30 (public...
by Jan Talts | Apr 16, 2020 | In the News
Researchers at the biotech company Amniotics in Lund has developed a lung specific stem cell for treatment of covid-19. The market for treating lung- and airway diseases is valued at 47 billion Euro. – At present, we are working day and night to finish our process...
by Jan Talts | Apr 16, 2020 | In the News
Nio projekt för medicin och vaccin mot covid-19 pågår i Medicon...
by Kim Engqvist | Apr 1, 2020 | In the News
Amniotics™ is currently trying to help the local community as much as possible in the coronavirus crisis. We are donating our protective clothing that we use in our GMP laboratory to Region Skåne. These clothes, designed to minimize spread of particles are only used...
by Kim Engqvist | Mar 18, 2020 | Press Releases
Longboat Amniotics AB has changed its name to Amniotics AB, to emphasize our commitment to developing innovative and life-changing treatments based on our cell-based products from amniotic fluid. Our pipeline of cell-therapeutics is based on Mesenchymal Stem Cell,...
by Kåre Engkilde | Jan 21, 2020 | In the News
Longboat Amniotics had an article in Dagens Industri (text in Swedish), describing our quick progress and ambitions. https://www.di.se/brandstudio/amniotics/unika-stamceller-ur-fostervatten/
by Kim Engqvist | Jul 3, 2019 | In the News
Longboat Amniotics raised SEK 20M in a new investment round in June. The Investment will be used for building a GMP production and further develop the pipeline of tissue specific mesenchymal stem cells. https://lnkd.in/em9KDEshttps://lnkd.in/ePBb_Ca
by Kim Engqvist | Jun 12, 2019 | In the News
Longboat Amniotics was featured in the June edition of Biopharma Deal Makers https://lnkd.in/eCknTwP
by Kim Engqvist | Mar 18, 2019 | Press Releases
The Board of Longboat Amniotics announces a change of CEO in the company as from June 1st. Kåre Engkilde, PhD Immunology, currently working for Agilent Technologies in Denmark where he is Development Manager, Clinical & Medical Affairs, is appointed as Longboat’s...
by Kim Engqvist | Mar 26, 2018 | Press Releases
Fast Development in Longboat Explorers AB In March, Longboat Explorers AB has graduated from the Incubator Environment of SmiLe in Lund and it has become “Alumni”. This is in recognition of the company’s fast development from the initial development phase to a...
Recent Comments